growth/size/body
|
• mice exhibit a significantly lower body weight than control mice at all time points between 3 and 12 weeks of age
|
|
• mice show significant deceleration of body weight growth beginning at 3 weeks of age
|
cardiovascular system
|
• at 4 weeks of age, mice exhibit skeletal reorganization of the myocardium with significantly reduced mRNA expression of cytoskeleton-related genes (vinculin, alpha/beta-tubulin, and alpha-actinin) and decreased levels of cytoskeletal proteins (vinculin, alpha/beta-tubulin, and TNNT2/cTNT) in myocardial tissue relative to controls
• mRNA expression of cell polarity-related genes (Pard3 and Scrib) and expression of the polarity proteins SCRIB and CRB2 are significantly lower at 4 weeks, suggesting myocardial tissue polarity defects
|
|
• at 4 weeks of age, cardiomyocytes show a significant decrease in the immunofluorescence intensity of cytoskeletal proteins (vinculin, alpha/beta-tubulin, TNNT2/cTNT, and alpha-actinin), suggesting cardiomyocyte cytoskeletal rearrangements
• moreover, cardiomyocytes show a significant decrease in the fluorescence intensity of the polarity protein PARD3, consistent with disruption of myocardial tissue polarity
|
|
• mice show a significant decrease in LV anterior wall thickness at end systole starting from 4- to 24 weeks of age
|
|
• mice show a significant increase in both LV inner diameter and LV volume at end systole starting from 4- to 24 weeks of age
|
|
• at 4 weeks of age, mice exhibit biventricular enlargement with significantly larger bilateral ventricular volumes than controls
|
|
• at 4 weeks of age
|
|
• at 4 weeks of age
|
|
• mice develop dilated cardiomyopathy starting at 4 weeks of age
|
|
• after 4 weeks of age, mice show a progressive decline in left ventricular (LV) systolic function, as evidenced by a significant reduction in LV ejection fraction and fraction shortening, accompanied by an increase in both LV inner diameter and LV volume at end systole as well as a decrease in LV anterior wall thickness at end systole; differences become increasingly pronounced with advancing age
• mRNA expression levels of Nppa (natriuretic peptide type A) and Nppb (natriuretic peptide type B) are significantly increased within ventricular muscle tissue at 4 weeks of age, consistent with early cardiac dysfunction
|
muscle
|
• at 4 weeks of age, mice exhibit skeletal reorganization of the myocardium with significantly reduced mRNA expression of cytoskeleton-related genes (vinculin, alpha/beta-tubulin, and alpha-actinin) and decreased levels of cytoskeletal proteins (vinculin, alpha/beta-tubulin, and TNNT2/cTNT) in myocardial tissue relative to controls
• mRNA expression of cell polarity-related genes (Pard3 and Scrib) and expression of the polarity proteins SCRIB and CRB2 are significantly lower at 4 weeks, suggesting myocardial tissue polarity defects
|
|
• at 4 weeks of age, cardiomyocytes show a significant decrease in the immunofluorescence intensity of cytoskeletal proteins (vinculin, alpha/beta-tubulin, TNNT2/cTNT, and alpha-actinin), suggesting cardiomyocyte cytoskeletal rearrangements
• moreover, cardiomyocytes show a significant decrease in the fluorescence intensity of the polarity protein PARD3, consistent with disruption of myocardial tissue polarity
|
|
• mice develop dilated cardiomyopathy starting at 4 weeks of age
|
|
• after 4 weeks of age, mice show a progressive decline in left ventricular (LV) systolic function, as evidenced by a significant reduction in LV ejection fraction and fraction shortening, accompanied by an increase in both LV inner diameter and LV volume at end systole as well as a decrease in LV anterior wall thickness at end systole; differences become increasingly pronounced with advancing age
• mRNA expression levels of Nppa (natriuretic peptide type A) and Nppb (natriuretic peptide type B) are significantly increased within ventricular muscle tissue at 4 weeks of age, consistent with early cardiac dysfunction
|
cellular
|
• at 4 weeks of age, cardiomyocytes show cytoskeletal rearrangements, as indicated by reduced expression of cytoskeleton-related genes and proteins
|
mortality/aging
| N |
• mice exhibit no significant differences in survival curves relative to controls
|


Analysis Tools